Literature DB >> 16547676

Pancreatic segmentation on an embryological and anatomical basis.

Koichi Suda1, Bunsei Nobukawa, Masaru Takase, Takuo Hayashi.   

Abstract

Limited resection of the pancreas is recommended for low-grade malignancies such as mucin-producing tumors. We propose a system of segmentation of the pancreas for the purposes of limited resection. The proposed system has an anatomical and embryological basis, and divides the pancreas into four segments, namely the anterior head, posterior head, body and tail. These segments are based on the conventional anatomical division of the pancreas, identification of the originating primordium, and distribution of the ventral and dorsal pancreas.

Entities:  

Mesh:

Year:  2006        PMID: 16547676     DOI: 10.1007/s00534-005-1039-3

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  5 in total

Review 1.  Parenchyma-Sparing, Limited Pancreatic Head Resection for Benign Tumors and Low-Risk Periampullary Cancer--a Systematic Review.

Authors:  Hans G Beger; Benjamin Mayer; Bettina M Rau
Journal:  J Gastrointest Surg       Date:  2015-11-02       Impact factor: 3.452

Review 2.  Unraveling Pancreatic Segmentation.

Authors:  Yohann Renard; Louis de Mestier; Manuela Perez; Claude Avisse; Philippe Lévy; Reza Kianmanesh
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

Review 3.  Structural similarities and differences between the human and the mouse pancreas.

Authors:  Jurij Dolenšek; Marjan Slak Rupnik; Andraž Stožer
Journal:  Islets       Date:  2015       Impact factor: 2.694

4.  Imaging of the pancreatic duct by linear endoscopic ultrasound.

Authors:  Malay Sharma; Praveer Rai; Chittapuram Srinivasan Rameshbabu; Shalini Arya
Journal:  Endosc Ultrasound       Date:  2015 Jul-Sep       Impact factor: 5.628

Review 5.  The Pancreas and Known Factors of Acute Pancreatitis.

Authors:  Julia Walkowska; Nicol Zielinska; Piotr Karauda; R Shane Tubbs; Konrad Kurtys; Łukasz Olewnik
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.